World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
41709
World Ranking
15857
National Ranking
41

Overview

George Fountzilas is affiliated with Aristotle University of Thessaloniki in Greece and has a research focus centered predominantly in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields including Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics, and Surgery.

The scientist has contributed extensively to topics such as Cancer Genomics and Diagnostics, Head and Neck Cancer Studies, Lung Cancer Research Studies, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, and Ovarian Cancer Diagnosis and Treatment.

Fountzilas's publication record includes a number of recent papers, with highlights including:

  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group (2021) in Radiotherapy and Oncology
  • Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis (2021) in The Lancet Oncology
  • Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study (2024) in Journal of Clinical Oncology
  • Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial (2023) in Annals of Oncology
  • Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer (2023) in Journal of Clinical Oncology

The frequent co-authors collaborating with Fountzilas include Georgia-Angeliki Koliou, Amanda Psyrri, Dimitrios Pectasides, Elena Fountzilas, and Anna Koumarianou, indicating sustained scholarly partnerships.

Major publication venues where this scientist has consistently published include Annals of Oncology, Journal of Clinical Oncology, Cancers, Anticancer Research, and ESMO Open, reflecting a focus on oncology and clinical cancer research.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Wendy De Roock;Bart Claes;David Bernasconi;Jef De Schutter

  • Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis

    Pierre Blanchard;Pierre Blanchard;Anne Lee;Sophie Marguet;Julie Leclercq

  • Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

    Fergus J. Couch;Steven N. Hart;Priyanka Sharma;Amanda Ewart Toland

  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Miguel Martin;Frankie A Holmes;Bent Ejlertsen;Suzette Delaloge

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

    Antonis C. Antoniou;Xianshu Wang;Zachary S. Fredericksen;Lesley McGuffog

  • Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Richard Gray;Rosie Bradley;Jeremy Braybrooke;Zulian Liu

  • A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer

    Christopher A. Haiman;Gary K. Chen;Celine M. Vachon;Federico Canzian

  • Paclitaxel Plus Carboplatin Versus Gemcitabine Plus Paclitaxel in Advanced Non–Small-Cell Lung Cancer: A Phase III Randomized Trial

    Paris Kosmidis;Nick Mylonakis;Costas Nicolaides;Charalabos Kalophonos

  • Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer A Hellenic Co-operative Oncology Group study

    D V Skarlos;E Samantas;P Kosmidis;G Fountzilas

  • What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis

    Laureen Ribassin-Majed;Sophie Marguet;Anne W.M. Lee;Wai Tong Ng

  • Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Issa J. Dahabreh;Helen Linardou;Fotios Siannis;George Fountzilas

  • A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.

    G P Stathopoulos;K Syrigos;G Aravantinos;A Polyzos

  • Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

    Cornelis J A Punt;Attila Nagy;Jean-Yves Douillard;Arie Figer

  • Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

    M. Karthaus;A. Kretzschmar;H. Kröning;M. Biakhov

  • Carboplatin plus paclitaxel in unknown primary carcinoma : A phase II hellenic cooperative oncology group study

    Evangelos Briasoulis;Haralambos Kalofonos;Dimitris Bafaloukos;Epaminondas Samantas

  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.

    Benjamin Lacas;Alexandra Carmel;Cécile Landais;Stuart J Wong

  • Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

    Bernard Escudier;Jan Roigas;Silke Gillessen;Ulrika Harmenberg

Frequent Co-Authors

Helen Gogas
Helen Gogas National and Kapodistrian University of Athens
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Nicholas Pavlidis
Nicholas Pavlidis University of Ioannina
Drakoulis Yannoukakos
Drakoulis Yannoukakos Aristotle University of Thessaloniki
Graham G. Giles
Graham G. Giles University of Melbourne
Heli Nevanlinna
Heli Nevanlinna University of Helsinki
Fergus J. Couch
Fergus J. Couch Mayo Clinic
Diana Eccles
Diana Eccles University of Southampton
Ute Hamann
Ute Hamann German Cancer Research Center
Irene L. Andrulis
Irene L. Andrulis University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, the USA offers a variety of online degree options and accelerated pathways to launch or advance your healthcare career. Many registered nurses wonder, does rn to bsn require clinicals? Several programs now offer flexible solutions with minimal or no in-person clinical requirements, making it easier for working professionals to earn a BSN.

If you're aiming for advanced practice or leadership roles, exploring the shortest dnp program online can help you achieve your doctorate efficiently. There are also options for those seeking less intensive coursework, as highlighted by the easiest online dnp programs, which balance flexibility with rigorous training for higher-level nursing roles.

For prospective nurses or career changers, fast track medical programs, such as online LPN pathways, offer quicker routes into the profession. With these diverse online and accelerated options, students can tailor their education to their needs, scheduling, and career ambitions in medicine.

Best Scientists Citing George Fountzilas

Trending Scientists